LB 06
Alternative Names: LB-06Latest Information Update: 08 Nov 2024
Price :
$50 *
At a glance
- Originator LexBio Therapeutics
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research CNS disorders
Most Recent Events
- 30 Aug 2024 Early research in CNS disorders in China (unspecified route) prior to August 2024 (LexBio Therapeutics pipeline, August 2024)